RBC Capital Maintains Outperform Rating on Wave Life Sciences (WVE)

1 week ago 8

Jeff Lewis

Sun, April 12, 2026 astatine 4:18 PM CDT 2 min read

Wave Life Sciences Ltd. (NASDAQ:WVE) is 1 of the

8 Healthcare Stocks Insiders Are Buying. On April 7, 2026, RBC Capital expert Luca Issi lowered the terms people connected Wave Life Sciences Ltd. (NASDAQ:WVE) to $15 from $27 and maintained an Outperform standing arsenic portion of a Q1 biotech preview. Luca Issi said seasonal headwinds astir gross-to-net, reimbursement resets, and less selling days whitethorn beryllium exacerbated by upwind impacts, peculiarly for launching and in-clinic products, portion noting that a instrumentality of M&A enactment and clarity connected tariff and Most Favored Nation cause pricing could assistance offset broader macro pressures.

On March 27, 2026, BofA lowered its terms people connected Wave Life Sciences to $21 from $38 and maintained a Buy standing pursuing updated Phase 1 information for WVE-007 successful obesity. BofA said further information is needed to enactment the monotherapy case, but noted imaginable opportunities successful higher BMI patients and successful operation oregon attraction settings.

RBC Capital Maintains Outperform Rating connected Wave Life Sciences (WVE)

On March 26, 2026, Wave Life Sciences reported caller Phase 1 INLIGHT proceedings information for WVE-007, showing that a azygous 240 mg dose led to reductions successful visceral fat, waist circumference, and assemblage weight, portion preserving muscle, with up to 88% simplification successful Activin E sustained for astatine slightest 7 months. The attraction was mostly harmless and well-tolerated, with nary superior adverse events, and further cohorts showed akin trends, supporting plans to statesman a Phase 2a multidose survey successful the 2nd 4th of 2026 and further trials evaluating monotherapy and operation approaches.

Wave Life Sciences Ltd. (NASDAQ:WVE) develops RNA-based therapeutics.

While we admit the imaginable of WVE arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.

Disclosure: None. Follow Insider Monkey connected Google News.

Read Entire Article